LOGIN
Lidocaine Vs Bupivacaine for Cervical Medial Branch Block for Chronic Cervical Facet Arthropathy
December 2023
Lidocaine Vs Bupivacaine for Cervical Medial Branch Block for Chronic Cervical Facet Arthropathy
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1
Comparative Outcome of Lidocaine Versus Bupivacaine for Cervical Medial Branch Block in Chronic Cervical Facet Arthropathy: A Randomized Double-Blind Study.
World Neurosurg . 2023 Jul:175:e662-e668.Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
62 patients with chronic cervical facet syndrome were randomized to receive a cervical medial branch block with either lidocaine (n=31) or bupivacaine (n=31). The primary outcome of interest was the duration of 50% pain relief using a Kaplan-Meier survival estimate after 12 weeks. Secondary outcomes of interest included 75% pain reduction using a Kaplan-Meier survival estimate, pain at rest and du...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.